Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation

Significance Human cytosolic sulfotransferases (SULTs) regulate hundreds of signaling small molecules, yet little is known regarding their small-molecule regulation. Members of the SULT1 family harbor a conserved allosteric site that we hypothesize allows independent regulation of sulfonation in the 11 metabolic areas in which these isoforms operate. This hypothesis is validated using SULT1A3, which sulfonates and inactivates monoamine neurotransmitters. During validation it was discovered that tetrahydrobiopterin (THB), an essential cofactor in monoamine neurotransmitter biosynthesis, allosterically inhibits SULT1A3 with high affinity (Ki, 23 nM) and isozyme selectivity. Monoamine neurotransmitter metabolism shapes human behavior and social interactions and is a therapeutic target. These findings provide a paradigm for regulating sulfonation and a target for controlling neurotransmitter activity. Monoamine neurotransmitters are among the hundreds of signaling small molecules whose target interactions are switched “on” and “off” via transfer of the sulfuryl-moiety (–SO3) from PAPS (3′-phosphoadenosine 5′-phosphosulfate) to the hydroxyls and amines of their scaffolds. These transfer reactions are catalyzed by a small family of broad-specificity enzymes—the human cytosolic sulfotransferases (SULTs). The first structure of a SULT allosteric-binding site (that of SULT1A1) has recently come to light. The site is conserved among SULT1 family members and is promiscuous—it binds catechins, a naturally occurring family of flavanols. Here, the catechin-binding site of SULT1A3, which sulfonates monoamine neurotransmitters, is modeled on that of 1A1 and used to screen in silico for endogenous metabolite 1A3 allosteres. Screening predicted a single high-affinity allostere, tetrahydrobiopterin (THB), an essential cofactor in monoamine neurotransmitter biosynthesis. THB is shown to bind and inhibit SULT1A3 with high affinity, 23 (±2) nM, and to bind weakly, if at all, to the four other major SULTs found in brain and liver. The structure of the THB-bound binding site is determined and confirms that THB binds the catechin site. A structural comparison of SULT1A3 with SULT1A1 (its immediate evolutionary progenitor) reveals how SULT1A3 acquired high affinity for THB and that the majority of residue changes needed to transform 1A1 into 1A3 are clustered at the allosteric and active sites. Finally, sequence records reveal that the coevolution of these sites played an essential role in the evolution of simian neurotransmitter metabolism.

[1]  P. Riederer,et al.  Use of monoamine oxidase inhibitors in chronic neurodegeneration , 2017, Expert opinion on drug metabolism & toxicology.

[2]  M. Girvin,et al.  The structure of the catechin-binding site of human sulfotransferase 1A1 , 2016, Proceedings of the National Academy of Sciences.

[3]  L. Scott Opicapone: A Review in Parkinson’s Disease , 2016, Drugs.

[4]  T. Leyh,et al.  Isozyme Specific Allosteric Regulation of Human Sulfotransferase 1A1. , 2016, Biochemistry.

[5]  Christina M. Bergey,et al.  Dopamine pathway is highly diverged in primate species that differ markedly in social behavior , 2016, Proceedings of the National Academy of Sciences.

[6]  T. Leyh,et al.  Design and Interpretation of Human Sulfotransferase 1A1 Assays , 2016, Drug Metabolism and Disposition.

[7]  Jolene R. Bostwick,et al.  Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment‐Resistant Depression , 2015, Pharmacotherapy.

[8]  J. Vinther,et al.  Constraints on the timescale of animal evolutionary history , 2015 .

[9]  C. Falany,et al.  The Allosteric Binding Sites of Sulfotransferase 1A1 , 2015, Drug Metabolism and Disposition.

[10]  T. Leyh,et al.  3′-Phosphoadenosine 5′-Phosphosulfate Allosterically Regulates Sulfotransferase Turnover , 2014, Biochemistry.

[11]  L. Goya,et al.  Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  Alan E. Mark,et al.  Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies , 2014, Journal of Computer-Aided Molecular Design.

[13]  David S. Wishart,et al.  SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database , 2013, Nucleic Acids Res..

[14]  R. Minchin,et al.  Cytosolic Sulfotransferase 1A3 Is Induced by Dopamine and Protects Neuronal Cells from Dopamine Toxicity , 2013, The Journal of Biological Chemistry.

[15]  C. Falany,et al.  High Accuracy in Silico Sulfotransferase Models* , 2013, The Journal of Biological Chemistry.

[16]  Scott J. Russo,et al.  The brain reward circuitry in mood disorders , 2013, Nature Reviews Neuroscience.

[17]  M. Finel,et al.  Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates , 2013, PloS one.

[18]  Harald Schwalbe,et al.  Small-molecule binding sites on proteins established by paramagnetic NMR spectroscopy. , 2013, Journal of the American Chemical Society.

[19]  S. Almo,et al.  The gate that governs sulfotransferase selectivity. , 2013, Biochemistry.

[20]  T. Karak,et al.  Diversity of Catechin in Northeast Indian Tea Cultivars , 2012, TheScientificWorldJournal.

[21]  Pramod C. Nair,et al.  An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0. , 2011, Journal of chemical theory and computation.

[22]  D. Weinberger,et al.  Orientation and Cellular Distribution of Membrane-bound Catechol-O-methyltransferase in Cortical Neurons , 2011, The Journal of Biological Chemistry.

[23]  Miriam Gochin,et al.  Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket. , 2011, ACS chemical biology.

[24]  D. Logan,et al.  Sexual dimorphism in olfactory signaling , 2010, Current Opinion in Neurobiology.

[25]  M. Pereira,et al.  NMR structural analysis of epigallocatechin gallate loaded polysaccharide nanoparticles , 2010 .

[26]  Jackie C Bloomer,et al.  Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie” , 2009, Drug Metabolism and Disposition.

[27]  C. Falany,et al.  24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation The online version of this article (available at http://dmd.aspetjournals.org) contains supplementa , 2009, Drug Metabolism and Disposition.

[28]  C. Falany,et al.  Expression and Localization of Cytosolic Sulfotransferase (SULT) 1A1 and SULT1A3 in Normal Human Brain , 2009, Drug Metabolism and Disposition.

[29]  Keiji Tanaka,et al.  Conflict-induced behavioural adjustment: a clue to the executive functions of the prefrontal cortex , 2009, Nature Reviews Neuroscience.

[30]  C. Falany,et al.  24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity and Inhibition of LXR Activation , 2009 .

[31]  Bosco K. Ho,et al.  HOLLOW: Generating Accurate Representations of Channel and Interior Surfaces in Molecular Structures , 2008, BMC Structural Biology.

[32]  Simone Florian,et al.  Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. , 2007, The Biochemical journal.

[33]  Y. Matsubayashi,et al.  Peptide hormones in plants. , 2006, Annual review of plant biology.

[34]  Keith F. Tipton,et al.  The therapeutic potential of monoamine oxidase inhibitors , 2006, Nature Reviews Neuroscience.

[35]  C. Falany,et al.  Pharmacogenetics of human cytosolic sulfotransferases , 2006, Oncogene.

[36]  Eric J. Nestler,et al.  New approaches to antidepressant drug discovery: beyond monoamines , 2006, Nature Reviews Neuroscience.

[37]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[38]  Jennifer L. Martin,et al.  The Structure of Human SULT1A1 Crystallized with Estradiol , 2005, Journal of Biological Chemistry.

[39]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[40]  Mei Li,et al.  Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate. , 2005, Biochemical and biophysical research communications.

[41]  Richard D. Taylor,et al.  Modeling water molecules in protein-ligand docking using GOLD. , 2005, Journal of medicinal chemistry.

[42]  M. James,et al.  Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  N. Buu,et al.  CSF sulfoconjugated catecholamines in man: Their relationship with plasma catecholamines , 2005, Journal of Neural Transmission.

[44]  S. Benner,et al.  Phylogenomic approaches to common problems encountered in the analysis of low copy repeats: The sulfotransferase 1A gene family example , 2005, BMC Evolutionary Biology.

[45]  J. Andreassi,et al.  Molecular functions of conserved aspects of the GHMP kinase family. , 2004, Biochemistry.

[46]  G. Pacifici Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. , 2004, International journal of clinical pharmacology and therapeutics.

[47]  Richard D. Taylor,et al.  Virtual Screening Using Protein—Ligand Docking: Avoiding Artificial Enrichment. , 2004 .

[48]  N. Blau,et al.  Functional Tetrahydrobiopterin Synthesis in Human Platelets , 2004, Circulation.

[49]  R. Weinshilboum,et al.  A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. , 2004, Pharmacogenetics.

[50]  C. Falany,et al.  Regulation of MCF-7 Breast Cancer Cell Growth by β-estradiol Sulfation , 2002, Breast Cancer Research and Treatment.

[51]  E. Cavalieri,et al.  The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. , 2004, Methods in enzymology.

[52]  B. Ma,et al.  Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[53]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[54]  S. Lee,et al.  Dopamine‐dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease , 2003, Journal of neurochemistry.

[55]  C. Falany,et al.  Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. , 2002, Breast cancer research and treatment.

[56]  L. E. Johnston,et al.  Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[57]  G. Wagner,et al.  Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data. , 2000, Biochemistry.

[58]  I. Arts,et al.  Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. , 2000, Journal of agricultural and food chemistry.

[59]  A. Pietrabissa,et al.  Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs , 2000, European Journal of Clinical Pharmacology.

[60]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[61]  S. Hemmerich,et al.  Sulfotransferases of Two Specificities Function in the Reconstitution of High Endothelial Cell Ligands for L-selectin , 1999, The Journal of cell biology.

[62]  D. Goldstein,et al.  Dopamine sulphate: an enigma resolved. , 1999, Clinical and experimental pharmacology & physiology. Supplement.

[63]  M. Coughtrie,et al.  A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. , 1998, Molecular pharmacology.

[64]  R. Kelly,et al.  Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport* , 1996, The Journal of Biological Chemistry.

[65]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[66]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[67]  Y. Hattori,et al.  Lipopolysaccharide treatment in vivo induces tissue expression of GTP cyclohydrolase I mRNA , 1995, FEBS letters.

[68]  M. Yoshizumi,et al.  Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[69]  A. Feduccia Explosive Evolution in Tertiary Birds and Mammals , 1995, Science.

[70]  M. Girvin,et al.  Determination of local protein structure by spin label difference 2D NMR: the region neighboring Asp61 of subunit c of the F1F0 ATP synthase. , 1994, Biochemistry.

[71]  T. Visser Role of sulfation in thyroid hormone metabolism. , 1994, Chemico-biological interactions.

[72]  T. James,et al.  Molecular dynamics with weighted time-averaged restraints for a DNA octamer. Dynamic interpretation of nuclear magnetic resonance data. , 1993, Journal of molecular biology.

[73]  E. Werner,et al.  Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. , 1993, The Journal of biological chemistry.

[74]  N. T. Buu Relationship Between Catechol‐O‐Methyltransferase and Phenolsulfotransferase in the Metabolism of Dopamine in the Rat Brain , 1985, Journal of neurochemistry.

[75]  N. Buu Dopamine Sulfoconjugation in the Rat Brain: Regulation by Monoamine Oxidase , 1985, Journal of neurochemistry.

[76]  C. A. Nichol,et al.  Biopterin cofactor biosynthesis: GTP cyclohydrolase, neopterin and biopterin in tissues and body fluids of mammalian species. , 1984, Life sciences.

[77]  K. Rácz,et al.  Regional distribution of free and sulfoconjugated catecholamines in the bovine adrenal cortex and medulla. , 1984, Canadian journal of physiology and pharmacology.

[78]  R. Vandongen,et al.  Free and sulfate-conjugated catecholamines during exercise in man. , 1984, The Journal of clinical endocrinology and metabolism.

[79]  S. Sasakawa,et al.  Changes of platelet cell volumes in hypotonic solution. , 1983, Thrombosis research.

[80]  G. Ruget,et al.  Plasma free and sulfoconjugated catecholamines in healthy men. , 1982, European heart journal.

[81]  W. Lovenberg,et al.  Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis. , 1981, Science.

[82]  I. Solomon Relaxation Processes in a System of Two Spins , 1955 .